Satellite Banner
Technology Networks Header
Friday, August 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Lonza Introduces Fresh Human Pancreatic Islets
Thursday, March 21, 2013
New Clonetics™ fresh human pancreatic islets used in a variety of research areas.

2D Coded Sample Storage StarterPacks
Tuesday, March 19, 2013
New 2013 Starterpacks ideal for smaller biobanks, biorepositories or biotech companies.

Sistemic and PCT Initiate Study on Novel Stem Cell Characterization Technology
Wednesday, March 13, 2013
Sistemic announces signature of an agreement to allow PCT to initiate studies on SistemQC™ technology.

BAMBANKER Cell Freezing Medium Increases Cell Viability
Tuesday, February 26, 2013
Get more intact, viable cells with serum-free cell freezing medium.

Illumina Launches Infinium® HumanCore Arrays
Wednesday, February 06, 2013
Ideal screening array for biobanks, genome centers, and core labs.

Intelsius Celebrates 15 Years of Protecting Life’s Most Precious Cargo™
Monday, January 28, 2013
Company announces launch of 15th Anniversary Celebration year.

Automated Buffy Coat Isolation on Tecan’s Freedom EVO®
Friday, January 25, 2013
Tecan and IBBL have successfully co-developed an automated platform for buffy coat extraction based on a Freedom EVO® 200 workstation.

Hamilton Robotics Safeguards Precious Blood Transfers
Tuesday, January 22, 2013
Company launches Microlab® easyBlood STARlet workstation.

Cellular Dynamics Announces the Production of Human iPSC Lines Under cGMP Conditions
Thursday, January 17, 2013
cGMP iPSC lines enable the possible use of iPSC-derived human cells within a clinical setting.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 476
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv